[1]王蒙,杨柳易,杨婧,等.肾衰Ⅱ号方对5/6肾切除大鼠残余肾组织凋亡相关蛋白表达的影响[J].中国中医药信息杂志,2019,26(5):64-68.[doi:10.3969/j.issn.1005-5304.2019.05.014]
 WANG Meng,YANG Liuyi,YANG Jing,et al.Effects of Shenshuai Ⅱ Prescription on Apoptosis-related Protein Expression in Renal Tissue of Chronic Renal Failure Rats Induced by 5/6 Nephrectomy[J].zhongguo zhongyiyao xinxi zazhi,2019,26(5):64-68.[doi:10.3969/j.issn.1005-5304.2019.05.014]
点击复制

肾衰Ⅱ号方对5/6肾切除大鼠残余肾组织凋亡相关蛋白表达的影响

参考文献/References:

[1] ENE-IORDACHE B, PERICO N, BIKBOV B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC):a cross-sectional study[J]. Lancet Glob Health,2016,4:e307-e319.
[2] XU Y, LIU Y Q, GUO H L, et al. Apoptosis-associated speck-like protein containing a cARD deletion ameliorates unilateral ureteral obstruction induced renal fibrosis and endoplasmic reticulum stress in mice[J]. Mediators Inflamm,2018,2018:6909035.
[3] ZHOU J, ZHONG J Y, HUANG Z X, et al. TAK1 mediates apoptosis via p38 involve in ischemia-induced renal fibrosis[J]. Artif Cells Nanomed Biotechnol,2018,2018:1-10.
[4] 杨婧,王琛,邵命海,等.肾衰Ⅱ号方对5/6肾切除大鼠肾血流量和肾内氧耗影响及其作用机制[J].中国中西医结合肾病杂志,2011,12(7):578-581.
[5] 秦军燕,王琛,邵命海,等.肾衰Ⅱ号方对慢性肾功能衰竭大鼠肾组织AngⅡ及nNOS蛋白表达的影响[J].中国中西医结合杂志,2012,32(9):1280-1284.
[6] 程勤丽,徐亚赟,杨靖,等.益气养血祛瘀泄浊法对5/6(A/I)慢性肾衰竭模型大鼠蛋白尿及残余肾功能的保护作用[J].中国中西医结合肾病杂志,2017,18(7):570-573.
[7] DENG A H, TANG T, SINGH P, et al. Regulation of oxygen utilization by angiotensin Ⅱ in chronic kidney disease[J]. Kidney Int,2009,75:197-204.
[8] 朱敏杰,郝海英,陈洁,等.葛根素对肾缺血再灌注大鼠肾脏组织细胞凋亡的影响及其机制探讨[J].中国实验方剂学杂志,2016,22(23):127- 132.
[9] 吴坚,邹玺,刘沈林,等.健脾养正消癥方通过激活PI3K/AKT 信号通路减轻顺铂所致的肾毒性作用[J].中国实验方剂学杂志,2015,21(17):106-110.
[10] 杨婧,严睿俊,王琛.肾衰Ⅱ号方对慢性肾脏病患者肾功能及炎症因子的影响[J].中国中医药信息杂志,2014,21(12):15-18.
[11] 周圆,王琛,何立群,等.肾衰Ⅱ号方治疗CKD3-4 期患者的临床疗效观察[J].上海中医药大学学报,2011,25(4):37-40.
[12] YOGOSAWA S, YOSHIDA K. Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis[J]. Cancer Sci,2018,109:3376-3382.
[13] WANG J, PANG J, LI H L, et al. lncRNA ZEB1-AS1 as suppressed by p53 for renal fibrosis in diabetic nephropathy[J]. Mol Ther Nucleic Acids,2018,12:741-750.
[14] REHMAN M U, TAHIR M, QUAIYOOM K A, et al. Diosmin protects against trichloroethylene-induced renal injury in Wistar rats:plausible role of p53, Bax and caspases[J]. Br J Nutr,2013,110:699-710.
[15] CHIPUK J E, KUWANA T, BOUCHIEⅡR-HAYES L, et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis[J]. Science,2004,303:1010-1014.
[16] CHENG J Z, CUI R, CHEN C H, et al. Oxidized low-density lipoprotein stimulates p53-dependent activation of proapoptotic Bax leading to apoptosis of differentiated endothelial progenitor cells[J]. Endocrinology,2007,148:2085-2094.
[17] MEI S Q, LIN L, WEI Q, et al. Double knockout of Bax and Bak from kidney proximal tubules reduces unilateral urethral obstruction associated apoptosis and renal interstitial fibrosis[J]. Sci Rep,2017,7:44892-44898.
[18] LIU X X, DENG Y F, XU Y F, et al. MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1[J]. J Mol Cell Cardiol,2018,118:133-146.
[19] BRENNER B M, MEYER T W, HOSTETTER T H. Dietary protein intake and the progressive nature of kidney disease:The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease[J]. N Engl J Med,1982,307:652–659.
[20] EDDY A A. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions[J]. J Am Soc Nephrol,1994,5:1273-1287.
[21] NATH K A. Tubulointerstitial changes as a major determinant in the progression of renal damage[J]. Am J Kidney Dis,1992,20:1-17.(收稿日期:2019-01-01)(修回日期:2019-01-12;编辑:华强)

相似文献/References:

[1]尹智功,赵先锋.灯盏细辛注射液治疗慢性肾衰竭临床疗效及对有效血浆流量的影响[J].中国中医药信息杂志,2008,15(12):84.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(5):84.
[2]徐大龙,朱龙生,李梅,等.复方温肾解毒丸为主治疗慢性肾衰竭临床观察[J].中国中医药信息杂志,2006,13(10):62.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(5):62.
[3]韦先进,周富明,张忠贤,等.溺毒清合剂对慢性肾衰竭患者血清纤维化指标的影响[J].中国中医药信息杂志,2009,16(2):19.
 WEI Xian-jin,ZHOU Fu-ming,ZHANG Zhong-xian,et al.Effect of Niduqing on Indexes of Serum Fibrosis of CRF Patients[J].zhongguo zhongyiyao xinxi zazhi,2009,16(5):19.
[4]杨婧,严睿俊,王琛,等.肾衰Ⅱ号方对慢性肾脏病患者肾功能及炎症因子的影响[J].中国中医药信息杂志,2014,21(12):15.[doi:10.3969/j.issn.1005-5304.2014.12.005]
 YANG Jing,YAN Rui-jun,WANG Chen,et al.Effects of Meliorated Renal Failure Decoction on Renal Function and Inflammatory Cytokines in Patients with Chronic Kidney Disease at 3-4 Stage[J].zhongguo zhongyiyao xinxi zazhi,2014,21(5):15.[doi:10.3969/j.issn.1005-5304.2014.12.005]
[5]张 琼,张茂平,张 军,等.活血消癥治疗慢性肾衰竭临床观察[J].中国中医药信息杂志,2004,11(3):250.
[6]刘学耀,洪钦国.尿毒清胶囊治疗慢性肾衰竭及对一氧化氮 和血浆内皮素水平的影响[J].中国中医药信息杂志,2004,11(6):480.
 LIU Xue-yao,HONG Qin-guo.Clinical Effects and Influences of the Level of NO and ET on CRF Patients with Capsule Niaoduqing[J].zhongguo zhongyiyao xinxi zazhi,2004,11(5):480.
[7]杨婧,祝婷婷,王琛.肾衰Ⅱ号方对慢性肾功能衰竭大鼠肾组织NF-κB/TNF-α信号通路表达的影响[J].中国中医药信息杂志,2018,25(8):58.[doi:10.3969/j.issn.1005-5304.2018.08.014]
 YANG Jing,ZHU Ting-ting,WANG Chen.Effects of Shenshuai Decoction on NF-B /TNF- Signaling Pathway Expressions in Renal Tissues of Chronic Renal Failure Rats[J].zhongguo zhongyiyao xinxi zazhi,2018,25(5):58.[doi:10.3969/j.issn.1005-5304.2018.08.014]
[8]祝婷婷,王琛,杨婧,等.肾衰Ⅱ号方对5/6肾切除大鼠肾组织形态及肿瘤坏死因子-α表达的影响[J].中国中医药信息杂志,2017,24(7):54.[doi:10.3969/j.issn.1005-5304.2017.07.013]
 ZHU Ting-ting,WANG Chen,YANG Jing,et al.Effects of Shenshuai Ⅱ Prescription on Renal Morphology and Expression of TNF-α in Rats with 5/6 Kidney Ablation/Infarction[J].zhongguo zhongyiyao xinxi zazhi,2017,24(5):54.[doi:10.3969/j.issn.1005-5304.2017.07.013]

备注/Memo

基金项目:国家自然科学基金(81573946);上海市科学技术委员会科研计划项目(16401931700);上海市进一步加快中医药事业发展三年行动计划建设项目(Y2018-2020-FWTX-7005)
通讯作者:王琛,E-mail:chenwang42@163.com

更新日期/Last Update:

2019-04-21